C. Henry

Requirement of Cys399 for Processing of the Human Ecto-ATPase (NTPDase2) and Its Implications for Determination of the Activities of Splice Variants of the Enzyme*

T. K. Harden, J. Boyer, C. Henry, 2003, Journal of Biological Chemistry.

Does the haemosiderin iron core determine its potential for chelation and the development of iron-induced tissue damage?

R. Crichton, R. Ward, R. Legssyer, 2000, Journal of inorganic biochemistry.

New 8-hydroxyquinoline and catecholate iron chelators: influence of their partition coefficient on their biological activity.

G. Lescoat, R. Crichton, F. Thomas, 2001, Biochemical pharmacology.

Evaluation of new iron chelators and their therapeutic potential

R. Crichton, R. Ward, Ying Zhang, 2002 .

Iron mobilisation and cellular protection by a new synthetic chelator O-Trensox.

G. Lescoat, P. Brissot, R. Crichton, 1998, Biochemical pharmacology.

Heterogeneous expression of GABA receptor‐like subunits LCCH3 and GRD reveals functional diversity of GABA receptors in the honeybee Apis mellifera

J. Guiramand, M. Vignes, C. Cohen‐Solal, 2020, British journal of pharmacology.